Merck Analysts Slash Their Forecasts After Q2 Results
Merck Analysts Slash Their Forecasts After Q2 Results
Merck & Co Inc (NYSE:MRK) reported better-than-expected second-quarter earnings and sales results on Tuesday.
默沙東公司（NYSE:MRK）於週二發佈了超出預期的第二季度收益和銷售業績。
The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15.
該公司發佈季度銷售額爲161億美元，同比增長7％，超過了158.4億美元的共識估計。不包括外匯影響，銷售額增長了11%。默沙東公司報告調整後的每股收益爲2.28美元，轉變爲每股虧損（2.06）美元，超過了2.15美元的共識。
Merck revised and narrowed its full-year 2024 forecasts. The company expects 2024 sales of $63.4 billion—$64.4 billion, compared to previous guidance of $63.1 billion—$64.3 billion and the consensus of $64.34 billion.
默沙東公司修訂並縮小了其2024年全年預測範圍。該公司預計2024年銷售額爲634億至644億美元，相比之前的指引631億至643億美元和共識643.4億美元有所增長。
The U.S. pharma giant expects 2024 adjusted EPS of $7.94 to $8.04, compared to prior guidance of $8.53-$8.65 and consensus of $8.16. The outlook includes one-time charges of $0.77 per share For Harpoon and Eyebio acquisitions.
這家美國製藥巨頭預計2024年調整後的每股收益爲7.94至8.04美元，而之前的指引爲8.53-8.65美元和8.16美元的共識。展望包括Harpoon和Eyebio收購的一次性費用每股0.77美元。
Merck shares fell 1.6% to trade at $113.37 on Wednesday.
默沙東公司的股價於週三下跌1.6％，報價113.37美元。
These analysts made changes to their price targets on Merck following earnings announcement.
這些分析師在業績公佈後對默沙東的價格目標進行了更改。
- UBS analyst Colin Bristow maintained Merck with a Buy and lowered the price target from $148 to $142.
- Wells Fargo analyst Mohit Bansal maintained the stock with an Equal-Weight and cut the price target from $140 to $125.
- B of A Securities analyst Geoff Meacham maintained Merck with a Buy and lowered the price target from $150 to $145.
- 瑞銀分析師Colin Bristow對默沙東的買入評級和股價目標從148美元下調至142美元。
- 富國銀行分析師Mohit Bansal維持公司的中性評級，將股價目標從140美元下調至125美元。
- BofA證券分析師Geoff Meacham維持默沙東的買入評級，將股價目標從150美元下調至145美元。
- Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
- 吉姆·克雷默表示，在聯邦基金利率下調週期之前，這家家居改善連鎖店是一個買入的選擇：“我會在明天買進一些股票。”